Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
170
天
Incidence and risk factors related to ocular adverse effects caused by S-1 chemotherapy
作者
Tomoyuki Kamao; Masakazu Yamada; Atsushi Shiraishi; Jo Sakai; Yuichi Ohashi展开收起
作者单位
1. Department of Ophthalmology, Ehime University Graduate School of Medicine, Toon, Japan; 2. Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan; 3. Department of Ophthalmology, Kasai City Hospital, Kasai, Japan; 4. Department of Ophthalmology, Minami Matsuyama Hospital, Matsuyama, Japan展开收起
190
天
Challenge to the concept of surgical dose-response for moderate to large angle exotropia
作者
Soh Youn Suh; Qingyu Meng; Ami Tamhaney; Joseph L. Demer展开收起
作者单位
1. Department of Ophthalmology, University of California, Los Angeles, USA; 2. Stein Eye Institute, UCLA, Los Angeles, USA; 3. David Geffen Medical School, University of California, Los Angeles, USA; 4. Peking University People’s Hospital, Beijing, China; 5. Department of Neurology, University of California, Los Angeles, USA; 6. Neuroscience Interdepartmental Program, University of California, Los Angeles, USA; 7. Bioengineering Department, University of California, Los Angeles, USA展开收起
117
天
Efficacy of ripasudil-brimonidine fixed-dose combination in secondary glaucoma associated with uveitis: a retrospective study
作者
Kenji Miyao; Masaya Imazeki; Tomoyuki Oyama; Shunsaku Nakai; Takayuki Kanda; Masaru Takeuchi展开收起
作者单位
1. Department of Ophthalmology, National Defense Medical College, Tokorozawa, Japan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天